ArticleClinical ophthalmology (Auckland, N.Z.)2025
Can Laser Retinopexy Prevent Retinal Detachment in Asymptomatic, High-Risk Eyes?
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Five-year risk of rhegmatogenous retinal detachment following prophylactic laser retinopexy for retinal breaks and lattice degeneration: a real-world analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Encircling Laser Prophylaxis for Retinal Detachment in Stickler Syndrome: The Impact on Visual Field.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significant literature evidence of retinal detachment prophylaxis safety and effectiveness for asymptomatic but high-risk eyes has appeared during the last five years. But it is still deemed "insufficient evidence to guide management" of asymptomatic fellow eyes in the American Academy of Ophthalmology's Preferred Practice Pattern for 2025. However, both focal and encircling prophylaxis for asymptomatic fellow eyes with lattice degeneration, and encircling laser prophylaxis for asymptomatic fellow eyes with attached posterior vitreous, now justify treatment consideration versus continued observation, based on the evidence we do have, even though it is not "level one".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.